Making the Business Case for Technology at the Intersection of Cost and Quality
Infection preventionists, environmental services directors, purchasing managers and members of the hospital C-suite are finding themselves at the intersection of cost and quality when it comes to evaluating technology for the prevention of healthcare-associated infections (HAIs). In this report, we take a look at the fiscal trends affecting hospital reimbursement, the necessity of achieving return on investment (ROI), and the importance of making an effective business case for infection control-related services and technologies.
Making the business case for infection prevention-related products and services to help avoid hospital-acquired conditions and infections -- and hospital readmissions -- is an imperative within the value-based purchasing framework. This report helps infection preventionists and members of the hospital C-suite understand how to find ROI in a technology-related capital purchase.
Takeaways for Your Business